Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MEF2C anticorps (pSer222)

MEF2C Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN6254109
  • Antigène Voir toutes MEF2C Anticorps
    MEF2C (Myocyte Enhancer Factor 2C (MEF2C))
    Épitope
    • 28
    • 27
    • 15
    • 10
    • 10
    • 9
    • 8
    • 8
    • 7
    • 7
    • 7
    • 7
    • 7
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer222
    Reactivité
    • 169
    • 84
    • 59
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 170
    • 5
    • 1
    Lapin
    Clonalité
    • 173
    • 3
    Polyclonal
    Conjugué
    • 79
    • 15
    • 10
    • 10
    • 8
    • 8
    • 6
    • 6
    • 6
    • 6
    • 6
    • 6
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp MEF2C est non-conjugé
    Application
    • 123
    • 89
    • 46
    • 33
    • 18
    • 17
    • 7
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Western Blotting (WB)
     Réactivité croisée
    Humain
    Homologie
    bovine, chicken, guinea pig, mouse, non-human primate, rat, sheep
    Purification
    Antigen Affinity Purified from Pooled Serum
    Immunogène
    Synthetic phospho-peptide corresponding to amino acid residues surrounding Ser222 conjugated to KLH
    Top Product
    Discover our top product MEF2C Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Buffer
    100 μL in 10 mM HEPES (  pH 7.5), 150 mM NaCl, 100 μg per ml BSA and 50 % glycerol.
    Stock
    -20 °C
  • Brown, Still, Koche, Yim, Takao, Cifani, Reed, Gunasekera, Ficarro, Romanienko, Mark, McCarthy, de Stanchina, Gonen, Seshan, Bhola, ODonnell, Spitzer, Stutzke, Lavallée, Hébert, Krivtsov, Melnick et al.: "MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. ..." dans: Cancer discovery, Vol. 8, Issue 4, pp. 478-497, (2019) (PubMed).

  • Antigène
    MEF2C (Myocyte Enhancer Factor 2C (MEF2C))
    Autre désignation
    MEF2C (MEF2C Produits)
    Synonymes
    anticorps MEF2C, anticorps XMEF2C, anticorps si:ch211-202e12.2, anticorps C5DELq14.3, anticorps DEL5q14.3, anticorps 5430401D19Rik, anticorps 9930028G15Rik, anticorps AV011172, anticorps Mef2, anticorps RGD1563119, anticorps id:ibd5026, anticorps mef2c, anticorps wu:fc05b06, anticorps zgc:64184, anticorps zgc:85726, anticorps myocyte enhancer factor 2C, anticorps MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C), anticorps myocyte enhancer factor 2cb, anticorps MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C) L homeolog, anticorps myocyte enhancer factor 2ca, anticorps MEF2C, anticorps mef2c, anticorps mef2cb, anticorps mef2c.L, anticorps Mef2c, anticorps mef2ca
    Poids moléculaire
    '51 kDa
    ID gène
    4208
    UniProt
    Q06413
    Pathways
    Neurotrophin Signaling Pathway, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Chromatin Binding, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Toll-Like Receptors Cascades, BCR Signaling
Vous êtes ici:
Support technique